AM Rx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.2/10
Best for: insured patients who want help getting a brand GLP-1 covered
AM Rx falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $106 a month for the medication, plus a required membership; its compounded semaglutide, at $297, is 49% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
medication only; a membership is required on top
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
AM Rx is a telehealth weight-loss membership whose site names AM Rx, LLC as operator; FDA's June 2026 warning letter went to FitRX, LLC doing business as AM RX, the company behind Zealthy. Its all-in compounded plans cost $297 a month for semaglutide and $449 for tirzepatide after a cheaper first month. Insurance coordination for brand GLP-1s can bring copays to $25, but the $135 monthly membership is still required.
Is AM Rx legit?
AM Rx is a real, operating US company, and the FDA has issued it 3 warning letters. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate AM Rx 5.2/10 overall.
Is there an AM Rx promo or coupon code?
AM Rx has no code to type in. The current offer: Limited Time: $96 off your first month / $96 off AM Rx Weight Loss Program (. It applies at checkout on its own. Coupon sites advertising an "AM Rx promo code" are not a source we can vouch for.
See how AM Rx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to AM Rx
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
AM Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro
- Starting price
- $106/mo + membership
- Availability
- All 50 states
- FDA status
- 3 FDA warning letters (details below)
How AM Rx scores
Six columns, each one computed from something AM Rx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
2.1/10$297/month is 49% above the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
2.5/10No price appears until the medical intake is finished. A live video visit is required, which is slower but the more careful intake.
Trust & Safety15%
2.0/10The FDA has issued it 3 warning letters. No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on AM Rx
Last checked October 2026- Checked the listed price across 6 dose or plan tiers
- Checked state coverage: all 50
- Checked FDA warning letters for AM Rx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with AM Rx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1AM Rx shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2The intake requires a live video visit with a clinician before a first prescription, which takes longer than a written form and is the more careful route.
- 3Ask AM Rx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $297, tirzepatide $449. That leaves out membership fees, first-month rates and insurance copays.
- AM Rx serves all 50 states.
- The FDA has issued AM Rx 3 warning letters. They are covered in the enforcement section below; read what they allege before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting AM Rx
- Phone
- (585) 699-1164
- AM Rx offers email support
Cancelling AM Rx
Taken from the terms AM Rx publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Monthly membership; renews until canceled
- Refund policy
- No refunds on medication, membership or visit fees; refund only if found ineligible for compounded GLP-1 (30-day guarantee)
- Early-termination fee
- None
Medications AM Rx lists
AM Rx lists semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
As low as $25/mo in copays with insurance coordination and an approved prior authorization; the AM Rx membership is still required.
$217 for the first month, then $297 per month. Compounded semaglutide is included while the plan stays active.
$349 for the first month, then $449 per month. Compounded tirzepatide is included while the plan stays active.
As low as $106 a month when a 3-month supply is bought, with shipping; the recurring AM Rx membership is billed on top. A 1-month price is not published.
As low as $216 a month when a 3-month supply is bought, with shipping; the recurring AM Rx membership is billed on top.
Standard $135/mo membership, $39 first month; renews monthly. Medication is billed separately unless you choose a bundle.
Check the price yourself before you pay
Every figure here comes from AM Rx's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Serves all 50 states
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Against it
- Semaglutide costs $297 a month, 49% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $449 a month, 67% above the $269 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued AM Rx 3 warning letters. Read what they allege: a letter flags a problem but does not by itself rule a seller out
- Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What AM Rx charges
AM Rx lists $106/month for the medication, plus a required membership.
- Brand-name semaglutide with insurance: $25/month + membership
- Compounded semaglutide: $217 first month, then $297/month
- Compounded tirzepatide: $349 first month, then $449/month
- Compounded semaglutide (3-month supply): $106/month + membership
- Compounded tirzepatide (3-month supply): $216/month + membership
- Required AM Rx membership (subscription, separate from medication): $39 first month, then $135/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so AM Rx's $297 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Some of AM Rx's prices are for the medication alone, with a membership billed on top, so read the terms you agree to at checkout before you pay. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Oak dispenses semaglutide and tirzepatide from $100/month, which makes it the fair comparison to run before you commit here.
What AM Rx dispenses
AM Rx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
AM Rx tells you that it treats patients in all 50 states. The FDA has issued AM Rx 3 warning letters, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If AM Rx will not tell you, treat that as a warning sign. Across the market, the FDA's GLP-1 warning letters are mostly about what sellers said rather than what pharmacies made. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
It fits if
- you need access wherever you live
- you want to try routing the cost through your insurance, where coverage is decided in three steps
Our read
AM Rx costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. The catch is disclosure, which is why AM Rx scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
AM Rx falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $106 a month for the medication, plus a required membership; its compounded semaglutide, at $297, is 49% above the $199 median among the sellers we compare.
Before you pay AM Rx
Starting at $106 a month for the medication, plus a required membership. Check today's price, then start the intake.
Where AM Rx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to AM Rx sets more sellers in the same category beside AM Rx on price, states and what the price includes.
Frequently Asked Questions
How to check AM Rx yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
Every seller that ships to your state, side by side: Alabama, Delaware, Iowa, Kentucky, Massachusetts, Oklahoma, Rhode Island, Washington and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
AM Rx has an FDA warning letter on record, dated June 8, 2026
This letter concerns false & misleading claims/misbranded (telehealth). A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this AM Rx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See AM Rx's current pricing
Plans start at $106 a month for the medication, plus a required membership. Whether you qualify is a clinician's decision, made after your intake.